(Bloomberg) -- U.K. stocks including SkyePharma Plc
declined after the drug-formulation company said its U.S.
application for an asthma medicine may be delayed.
Daily Mail and General Trust Plc rose. Morgan Stanley
advised investors to buy shares in the publisher of the U.K.'s
Daily Mail newspaper following a slump in the past three months.
Read more at Bloomberg Stocks News
declined after the drug-formulation company said its U.S.
application for an asthma medicine may be delayed.
Daily Mail and General Trust Plc rose. Morgan Stanley
advised investors to buy shares in the publisher of the U.K.'s
Daily Mail newspaper following a slump in the past three months.
Read more at Bloomberg Stocks News
No comments:
Post a Comment